Rachelle Jacques
2022
In 2022, Rachelle Jacques earned a total compensation of $3.6M as Former President and Chief Executive Officer at Akari Therapeutics Plc.
Compensation breakdown
| Bonus | $875,000 |
|---|---|
| Option Awards | $1,965,991 |
| Salary | $458,333 |
| Stock Awards | $253,410 |
| Other | $49,865 |
| Total | $3,602,599 |
Jacques received $2M in option awards, accounting for 55% of the total pay in 2022.
Jacques also received $875K in bonus, $458.3K in salary, $253.4K in stock awards and $49.9K in other compensation.
Rankings
In 2022, Rachelle Jacques' compensation ranked 982nd out of 5,756 executives tracked by ExecPay. In other words, Jacques earned more than 82.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 982 out of 5,756 | 83rd |
Division Manufacturing | 454 out of 3,133 | 86th |
Major group Chemicals And Allied Products | 164 out of 1,419 | 88th |
Industry group Drugs | 147 out of 1,320 | 89th |
Industry Pharmaceutical Preparations | 107 out of 966 | 89th |
Source: SEC filing on June 3, 2024.
Jacques' colleagues
We found one more compensation record of an executive who worked with Rachelle Jacques at Akari Therapeutics Plc in 2022.
2022
Torsten Hombeck
Akari Therapeutics Plc